Jessie Salamba Chirwa

Biographic Data

ID9068667
NAMEJessie Salamba Chirwa
GIVEN NAMESJessie Salamba
FAMILY NAMEChirwa
SIGNATURECHIRWA J S
AFFILIATIONSMinistry of Health
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2025
H-INDEX0

  • The case for investing in provider-administered subcutaneous DMPA

    Open AccessHolly M Burke, Wingston Ng’ambi et al.ARTICLEBMJ Global Health2025

    INTRODUCTION: Depot medroxyprogesterone acetate (DMPA) is available as provider-administered intramuscular (DMPA-IM) and subcutaneous injections (PA DMPA-SC), as well as DMPA-SC self-injection (SI), which enhances accessibility and continuation by reducing facility visits. However, DMPA-SC has a higher unit price than DMPA-IM, and low SI uptake can undermine its cost-effectiveness. This study assessed whether PA DMPA-SC's potential benefits justi…

  • Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi

    Open AccessChelsey Porter Erlank, Gracious Ali et al.ARTICLEPLOS Global Public Health2023

    Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC. However, the rate of clients opting to self-inject DMPA-SC has remained lower than early acceptability studies suggested. Providers play an instrumental role in building client confidence to self-inject through counselling/training. Th…